Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Clinical significance of the indirect biochemical markers for detecting liver fibrosis in adult patients with chronic HCV infection

6th Euro-Global Conference on Infectious Diseases

Huseyin Kayadibi

Hitit University School of Medicine, Turkey

Keynote: J Infect Dis Ther

DOI: 10.4172/2332-0877-C1-031

Abstract
Hepatitis C virus (HCV) has been considered to be one of the main causes of the liver fibrosis. Estimation of the stage of liver fibrosis is mandatory for the management of patients with HCV infection. Although liver biopsy is still the gold standard diagnostic tool to assess the stage of liver fibrosis, it is not available to be performed for all patients, and has lots of complications, as well as non-invasive tests may play a role in the evaluation of liver fibrosis. Moreover, the accuracy of liver biopsy is limited due to the intra- and inter-observer variability and sampling errors. Therefore, the development of simple, cheap and accurate biochemical markers is necessary to detect the liver fibrosis. Platelet count, AST to ALT Ratio, AST to platelet ratio index, age platelet index, Pohl score, Forns index, FIB-4, hepascore, fibrometer and fibrotest are the most commonly used indirect biochemical markers used for the detection of liver fibrosis. Instead of a single biochemical marker, use of the combinations of these non-invasive biochemical markers for liver fibrosis may increase the diagnostic accuracy of the single biochemical markers and may markedly reduce the need for liver biopsy. Therefore, use of these biochemical markers as an initial step before the invasive and expensive procedures is important in routine clinical practice for the favor of patients.
Biography

Huseyin Kayadibi received a Degree in Medicine from the GATA School of Medicine (Turkey) in 2000. He is an Associate Professor in Medical Biochemistry at Hitit University School of Medicine, where he is the Head of Medical Biochemistry. He worked at Pasarow Mass Spectrometry Laboratory, University of California Los Angeles in 2012 as a Visiting Scholar. He has been a Co-investigator on NIH and other international projects about metabolomics, proteomic and lipidomic analysis. He is the Member of EFLM Working Group Test Evaluation and IFCC Working Group Cerebrospinal Fluid Proteins. He has published more than 70 papers in peer reviewed journals. His research interests are non-invasive assessment of liver fibrosis, separation techniques and mass spectrometry.

Top